FINANCIAL RESULT QTR1

Date: 13.08.2026 Department of Corporate Services, BSE Limited, Phiroze Jeejeebhoy Towers, Dalal Street, Fort, Mumbai – 400 001. Ref: Scrip Code: 526075 Sub: Outcome of the Board Meeting held on 13th August, 2026. Dear Sir/Madam, Pursuant to Regulation 33 and Regulation 30 read with Part A of Schedule III of SEBI (LODR) Regulations, 2015, we hereby inform you that the Board of Directors of the Company at its Meeting held today i.e. 13th August, 2026 through online mode has inter-alia adopted and approved the following: 1) Appointment of Mr. Surbhit Shah (DIN: 01993300) Executive Director of the company as a Chairman of the Board of Director(s). 2) The Standalone Un-Audited Financial Results for the Quarter ended on 30th June, 2026. 3) Limited Review Reports by Statutory Auditors on Standalone Unaudited financial results for the quarter ended on 30th June, 2026. The Meeting of Board of Directors of the Company commenced from 3.00 PM and closed at 3.30 PM. We request you to kindly take the same in your record. Thanking you, For Rekvina Laboratories Limited Chairman and Executive Director Surbhit Shah DIN: 01993300 CIN: L24231GJ1988PLC01145 Regd. Office: 36, Sampatrao Colony, Next to Royal Hotel, Alkapuri, Baroda -39007 Email Id: info@rekvinalaboratories.com, rekvinalimited@gmail.com Cont. No.: 0265-2362966 REKVINA LABORATORIES LIMITED CIN: L24231GJ1988PLC011458 Standalone Financial Result for the period ended on 30 June 2026 Rs. in Lacs Quarter Ended Year Ended Particulars 30 June 2026 31 March 2026 30 June 2025 31 March 2026 Un Audited Audited Un Audited Audited I Income Revenue From Operations 6 6.85 7 2.36 - 1 26.54 Total Income (I) 6 6.85 7 2.36 - 1 26.54 II Expenses Purchases of Stock-in-Trade 6 9.76 6 7.26 - 1 18.16 Changes in inventories of finished goods, Stock in Trade and work in -4.16 - - - Employee benefits expense 4 .40 6.41 2.70 2 2.99 Other expenses 8 .90 4.74 0.84 1 0.86 Total expenses (II) 7 8.90 7 8.41 3.54 1 52.01 III Profit/(loss) before tax (I-II) -12.05 -6.05 -3.54 -25.47 IV Tax expenses Current tax - - - - Total Tax expense (IV) - - - - V Profit/(loss) after tax for the period (III-IV) -12.05 -6.05 -3.54 -25.47 VI Other Comprehensive Income Total Other Comprehensive Income (VI) - - - - VII Total Comprehensive Income for the period (V+VI) -12.05 -6.05 -3.54 -25.47 VIII Earnings per equity share Basic -0.20 -0.10 -0.06 -0.42 Diluted -0.20 -0.10 -0.06 -0.42 For and on behalf of Board of Directors, Rekvina Laboratories Limited Surbhit Shah Place: Vadodara Chairman and Director Date: 13-08-2026 DIN: 01993300 REKVINA LABORATORIES LIMITED Notes to the Standalone Financial Result for the period ended on 30 June 2026 1 TheAboveStandaloneQuarterlyUnauditedFinancial ResultsofM/s.RekvinaLaboratoriesLimitedforthe quarterhavebeenreviewedandrecommendedbytheAuditCommitteeandthesamehasbeenapproved by the Board of Directors of the Company at its meeting held on 13.08.2026. This Results have been subjectedtolimitedReviewbythestatutoryAuditorofthecompanyM/sYMShah&Co.whohaveissued unmodified limited review report. 2 These stand alone financial results have been prepared in accordance with the recognition and measurementprincipleslaiddowninlndianAccountingStandard(lndA5)34-lnterimFinancialReporting, asprescribedunderSection133oftheCompaniesAct,2013,readwiththerelevantrulesissuedthereunder, and in compliance with therequirements ofRegulation 33of theSEBI (Listing Obligations andDisclosure Requirements) Regulations, 2015, and other accounting principles generally accepted in lndia 3 The Earing Per Shares has been computed in accordance with Indian Accounting Standard on Earing Per Shares (IND AS 33). 4 This statement is preparedas per IndianAccounting Standards(INDAS) notified undersection 133under CompaniesAct,2013readwithCompaniesAct2015(IndianAccountingStandardRules)asammendedand as per Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015. 5 Previousperiod's/yearfigureshavebeenregrouped/rearrangedwhereverconsidernecessarytoconfirm to the current period's / year classification. For and on behalf of Board of Directors, Rekvina Laboratories Limited Surbhit Shah Place: Vadodara Chairman and Director Date: 13/08/2026 DIN: 01993300 Y. M. SIIATI CO. CHARTERED ACCOUNTANTS IND!A 345, Third Floor, Tower A, Atlantis K 10, Opp. Reliance Centro, Sarabhai Main Boad, Vadodara -390007. Ph.: (O) 0265- a00S393, M: 9825.3 21493 E-mail : shilpJog@hotmail.com Website : www.caymshah.in lndependent Auditor's Review Report on the Quarter Ended Un-Audited Financial Results of the Company Pursuant to the Regulation 33 of the SEB| (l-isting Obligations and Disclosure Requirements) Regulations, 2015, as amended. Review Report to The Board of Directors Rekvina Laboratories Limited We have reviewed the accompanying statement of unaudited standalone financial results of Rekvina Laboratories Limited (the "company") for the 1tt quarter Ended 3o'h June 2026 (the "statement") attached herewith, being submitted by the Company pursuant to the requirements of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with SEBI Circular No. CIR/CFD/CMOL/44I2019, dated 29-03-2019. (The Circular). 2. The preparation ofthe statement in accordance with the recognition and measurement principles laid down in lndian Accounting Standard 34, lnterim Financial Reporting (lND AS 34) prescribed under Section 133 of the Companies Act, 2013 read with Rule 3 of Companies (tndian Accounting Standards) Rules, 2013 read with SEBI Circular No. CIR/CFDICM Dl/44/211.g, is the responsibitity of the Company's management and has been taken on record by the Board of Directors of the company. our responsibility is to issue a report on the Statement based on our review. We conducted our review in accordance with the standard on Review Engagements (SRE) 2014, Review of lnterim Financial lnformation Performed by the lndependent Auditor ofthe Entity issued by the lnstitute of Chartered Accountants of lndia. This standard requires that we plan and perform the review to obtain moderate assurance as to whether the Statement is free of material misstatement. A review is limited primarily to inquiries of company personnel and analytical procedures applied to financial data and thus provide less assurance than an audit. We have not performed an audit and accordingly, we do not express an audit opinion. Based on our review conducted as above, nothing has come to our attention that causes us to believe that the accompanying statement prepared in accordance with the recognition and measurement principles laid down in the applicable lndian Accounting Standards (lND AS) specified under Section 133 of the Companies Act, 2013, read with relevant rules issued there under and other recognized accounting practices and policies bas not disclosed the information required to be disclosed in terms of Regrllation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, including the manner in which it is to be disclosed or that it contains any material misstatement. The accompanying IND AS financial results for the corresponding quarter ending 30-06-2026 have been subject to a limited review or audit and based on the information compiled by Management and has been taken on record by the Board of Directors. Date:1f,.08.2026 FOR Y. M. SHAH & Co. Chartered Accountants PIace: Vadodara F. R. No.: I 14l24W Shah Partner M. No. l88l 23 UDIN: 26 I 88 I 23BEZxrtcT s9?